Menu
Recruiting NCT06876857

University of Central Florida CereBank

Observational Biospecimen Donation Brain Injury Brain Diseases

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Biospecimen Donation, Brain Injury, Brain Diseases. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have a brain biobank to meet the needs of research. Therefore, it is necessary for the University of Central Florida to establish a brain biobank.

Detailed description

The purpose of the University of Central CereBank is to be a brain repository to support the research of the faculty of the University of Central Florida College of Medicine. These research studies aim at improving the diagnosis and treatment of brain diseases, such as dementia, to advance medicine. The donated brains will be used for research and educational purposes.

Primary outcome measures

  • Receipt of donated brain tissue and biospecimens for research and educational purposes [Time frame: 75 years]

Eligibility criteria

Inclusion criteria

  • Be 18 years or older.
  • Able to provide informed consent. Persons who are unable to provide an informed consent will need a Legally Authorized Representative (LAR) to sign the informed consent.

Exclusion criteria

  • minors (under age 18).
  • prisoners.
  • pregnant women.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

United States · 1 center
  • University of Central Florida — Orlando

Identifiers

NCT: NCT06876857 · STUDY00007544

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗